about
Neuronal network disintegration: common pathways linking neurodegenerative diseasesPhenotypic Heterogeneity of Monogenic Frontotemporal DementiaClinicopathologic assessment and imaging of tauopathies in neurodegenerative dementiasThe utility of neuroimaging in the differential diagnosis of parkinsonian syndromesNeuroimaging biomarkers of neurodegenerative diseases and dementiaClinicopathological correlations in corticobasal degenerationThe corticobasal syndrome-Alzheimer's disease conundrumNeurodegenerative diseases target large-scale human brain networksThe binaural masking level difference: cortical correlates persist despite severe brain stem atrophy in progressive supranuclear palsy.Social cognitive deficits and their neural correlates in progressive supranuclear palsy.In vivo signatures of nonfluent/agrammatic primary progressive aphasia caused by FTLD pathologyRecent advances in the imaging of frontotemporal dementia.A review of the use of magnetic resonance imaging in Parkinson's disease.Charting Frontotemporal Dementia: From Genes to Networks.Seizures in corticobasal degeneration: a case report.Abnormal Resting-State Functional Connectivity in Progressive Supranuclear Palsy and Corticobasal Syndrome.Magnetic resonance imaging in progressive supranuclear palsy.Biomarkers in frontotemporal lobar degenerations--progress and challenges.Temporoparietal atrophy: a marker of AD pathology independent of clinical diagnosis.Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration.Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management.Anatomical differences between CBS-corticobasal degeneration and CBS-Alzheimer's disease.Impaired information integration contributes to communication difficulty in corticobasal syndromeSymmetric corticobasal degeneration (S-CBD).Association of ideomotor apraxia with frontal gray matter volume loss in corticobasal syndromeCaudate atrophy on MRI is a characteristic feature of FTLD-FUSImaging correlates of pathology in corticobasal syndrome.Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia.Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts.Neuroimaging in frontotemporal dementia.Automated, high accuracy classification of Parkinsonian disorders: a pattern recognition approach.Disrupted thalamocortical connectivity in PSP: a resting-state fMRI, DTI, and VBM studyMorphometric analysis of subcortical structures in progressive supranuclear palsy: In vivo evidence of neostriatal and mesencephalic atrophy.Behavioral variant frontotemporal dementia with corticobasal degeneration pathology: phenotypic comparison to bvFTD with Pick's disease.Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau).Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndromeThe feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson's syndrome.Advances in neuroimaging in frontotemporal dementia.Rates of brain atrophy and clinical decline over 6 and 12-month intervals in PSP: determining sample size for treatment trials.Clinical correlates of white matter tract degeneration in progressive supranuclear palsy.
P2860
Q26750287-F81AF75C-ED57-4DF2-9229-638767FEBD3AQ26782984-385E83C3-3011-409D-9002-EDCB2F8D452AQ27003078-E1829B29-C442-4755-86C2-DA610C334FA3Q27025731-99D3F065-7073-44D5-8100-B4C3CA46E6AEQ27691820-FA3886AD-BBCB-4C81-A246-E450A0CA238BQ28245070-80462516-D843-4B73-A519-F851A70917EAQ28250881-E24A453E-D9CE-48BD-BACD-94CF347FED24Q29614723-F497D43E-F0F8-4025-AA98-C4000FA36B1BQ30422494-86430B88-F81C-4330-B2F2-4E3254007164Q30466418-287DA720-4C71-4E3D-AAAC-16F2213255EFQ30568992-52CACC12-465D-4C9F-8FDA-14AAF6126A08Q30570862-01944E34-535C-49F0-A205-D423B49D4732Q30835548-0D7C6B9C-F79C-459B-92B4-06DE9450B842Q31029220-1F06CD79-159C-4B49-BF3B-A8B0D29F8A8FQ33690332-254BA1D3-011B-4808-BA39-64F30BA458B9Q33766237-9CC83928-EA9C-4368-A3B3-C6B30C4B0E82Q33779124-095C6B5B-F9C2-4F93-86C2-D4E328E18EFDQ33893515-FFEECEFD-2E30-4AC1-99DA-D69F41B5D2A1Q33926731-C56AF7BC-8674-47B8-9A5A-6370A1EB2974Q34028511-2EF9486D-78C6-421B-8F80-852D79AA5D4BQ34046590-A7B7FAEA-A494-448A-8253-BF31AD9B633FQ34066242-44B47571-2027-4A3E-8E0C-458EC747D575Q34095727-8EF76BD6-5500-4EAD-A13B-F8CF41F1FBFAQ34136201-2A1F0016-B660-4FF8-ADD8-C329ABCADB4FQ34308481-32C49E35-3529-4860-8587-05EAF23528D0Q34340214-548248BE-8328-4179-8675-0ED1FF2CF62CQ34370058-5F51F567-B3C5-476F-A402-7CF9F41074E3Q34552887-356A4516-7EDC-499C-999A-5E4CDEE2B878Q34554452-8883D5A9-2A54-4578-B813-26A985ED1FB8Q34682550-497C6864-428A-4E14-8545-68687F3D7BE4Q34838098-5F0CFF67-5C90-462E-B2D9-B79BA7E0F95CQ35202151-73CB7760-7EF9-4D1D-AF09-6D19C399C53BQ35479731-94C8349F-9BA5-4BEE-A4DE-9483A5E0AD0EQ35523746-C60C399D-6B7E-4363-91E7-F1BB0ECD395BQ35523801-63EEF94B-EA86-4131-AFB4-D910492CA7EAQ35540064-187110D9-29C7-452E-A9AC-325782AA70ADQ35693075-0AEE3F3B-F52D-41D1-BB47-B67957D830ADQ36097857-92DB9123-D00E-44E9-8C37-E6BCFC269933Q36101560-80F89AD1-11C9-43F1-B47F-B5E89CCFF740Q36107380-6E8156B5-2B5F-4666-B2B2-126BA80D297E
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Voxel-based morphometry in autopsy proven PSP and CBD
@en
Voxel-based morphometry in autopsy proven PSP and CBD.
@nl
type
label
Voxel-based morphometry in autopsy proven PSP and CBD
@en
Voxel-based morphometry in autopsy proven PSP and CBD.
@nl
prefLabel
Voxel-based morphometry in autopsy proven PSP and CBD
@en
Voxel-based morphometry in autopsy proven PSP and CBD.
@nl
P2093
P2860
P50
P1476
Voxel-based morphometry in autopsy proven PSP and CBD
@en
P2093
Bradley F Boeve
Jennifer L Whitwell
Joseph E Parisi
Keith A Josephs
P2860
P304
P356
10.1016/J.NEUROBIOLAGING.2006.09.019
P577
2006-11-13T00:00:00Z